Partner
Kyungjin KIM
Healthcare · Life Sciences
Expertise
Healthcare · Life Sciences
IP Litigation
IP Strategy Consulting
Trade Secret · Company Information Protection
Chemical
Pharmaceuticals · Biotechnology
US · Europe (IP Prosecution)
Japan (IP Prosecution)
Trademark · Design
IP Compliance
Employee Inventions
Copyright · Computer program
IP Transactions & Licensing
Recently reviewed Professionals
Kyungjin Kim, a member of the Intellectual Property and Healthcare Groups at Lee & Ko, specializes in various facets of intellectual property. Her primary focus encompasses patent litigation, IPTAB (Intellectual Property Trial and Appeal Board) trials, and counseling within the chemical, pharmaceutical, and biotechnology sectors. Beyond her expertise in these domains, her practice extends to advising on intellectual property rights, including trade secrets, unfair competition, trademarks, and copyrights. Her comprehensive approach ensures that clients receive tailored legal guidance across a spectrum of intellectual property challenges. Ms. Kim has been selected as the Rising Star of IP practice area by Legal Times in 2023 and the Rising Star (IP Stars) by Managing IP from 2018 to 2020.
Additionally, Ms. Kim specializes in providing strategic legal counsel and representation for the clients in healthcare sector, offering expert advice and litigation support.
Ms. Kim is admitted to the Korean Bar, Korean Patent Bar, and New York Bar.
Additionally, Ms. Kim specializes in providing strategic legal counsel and representation for the clients in healthcare sector, offering expert advice and litigation support.
Ms. Kim is admitted to the Korean Bar, Korean Patent Bar, and New York Bar.
Representative Cases
- [Patent and Trade Secret Litigation]
- Represented Novartis against many Korean generic companies, which was one of the biggest patent infringement disputes related to blockbuster drug for heart failure treatment
- Represented Bayer against Korean generic company in patent invalidation action and scope confirmation trial cases on contraceptive drug taking the No. 1 position
- Represented BMS against Korean generic companies in patent infringement and invalidation disputes related to blockbuster anticoagulant drug
- Represented Celgene in its patent invalidation action and scope confirmation action cases on anti-cancer drug
- Represented Hyosung Chemical against UOP in litigation for trade secret misappropriation and violation of license agreement related to propane dehydrogenation plant
- Represented LG Chem against 3M Company in patent infringement and invalidation disputes involving adhesive products for decorative use, optically clear adhesives for display
- Represented JNC against Merck in patent litigation and invalidation disputes related to liquid crystal composition patent
- Represented JNC and SK materials against SFC in patent litigation and invalidation disputes related to OLED dopant material patent
- [Counseling for Pharmaceutical Companies]
- Advised global pharmaceutical companies regarding biosimilar patent disputes
- Advised pharmaceutical companies on Pharmaceutical Affairs Act
- Reviewed and advised on various agreements
- [Intellectual Property Compliance]
- Conducted risk analysis of trade secret infringement and provided counseling on implementation of document management system for a major Korean chemical company
- Conducted risk analysis of trade secret infringement and provided strategy to protect its own technology for a catalyst company
- Provided guideline to manage the risk of trade secret infringement and protect the trade secret of a major Korean chemical company
- Educated employees on trade secret infringement protection for a major Korean chemical company and a Korean pharmaceutical company
- Reviewed and advised on various types of agreements including license agreement
Education
| 2018 | Northwestern University - LL.M. |
|---|---|
| 2012 | Sungkyunkwan University Law School |
| 2007 | Graduate School of Hanyang University - M.E. in Electronic Engineering |
| 2004 | Seoul National University - B.S. in Chemical Engineering |
Work Experience
| 2013-Present | Lee & Ko |
|---|---|
| 2018-2019 | K&L Gates LLP (Chicago Office) |
| 2012-2013 | Yulchon LLC |
| 2005-2008 | Samsung Electronics Co., Ltd. (Intellectual Property Group, LCD Division) |
| 2004 | Way with Roh Patent & Law Office |
Admissions
| 2012 | Admitted to bar, Korea |
|---|---|
| 2020 | Admitted to bar, New York |
| 2003 | Admitted to the Korean patent bar |
Languages
| Korean and English |
Awards and Recognitions
| 2024 | The Legal 500 Asia Pacific, recognized as Next generation Partners in the IP(PATMA) area |
|---|---|
| 2023 | Legal Times, recognized as Rising Star in the IP area |
| 2019-2020 | IP Stars - Rising Stars - South Korea (Managing IP) |
| 2018-2019 | IP Stars - Rising Stars - South Korea (Managing IP) |
Related news
Awards Ranking
'Legal 500 Asia Pacific 2024' ranks Lee & Ko in the top tier in 15 practice areas 2024.01.18Seminar/Event
Seminar on 'The Latest Trends in IP Practices and Issues in Japan' 2023.06.29Deals & Cases
Obtained a victory in a patent invalidation action related to the Soliris® use patent 2023.02.10Press & Releases
[Legal Times] [IP Law] Lee & Ko's IP Practice Group Hosted Seminar on Latest Trends in IP Court Precedents, Selection Inventions, Software Programs and Metaverse 2023.01.04Seminar/Event
Lee & Ko Seminar on 'Changes and Relevant Remedies in the Intellectual Property Environment' 2022.12.01Seminar/Event
The “Changes in the Landscape of Intellectual Property and How Best to Respond to Them” Webinar 2021.10.18Seminar/Event
Lee & Ko and Morgan Lewis to host a joint seminar on recent issues in pharmaceutical and bio-pharma industry 2019.09.19